Expose MASH [Formerly NASH]

Podcast science

⚔ Compare ☆ Watch Own this podcast?

🔄 Data last refreshed 5 hours ago

🤝

Make a deal with Expose MASH [Formerly NASH]

🔒 Paid proposals held safely in escrow — released only when the work's approved.

Ratings

N/A

Episodes

Cadence

0.1 ep/wk

Latest episode

8 months ago

🧰 Free analysis for Expose MASH [Formerly NASH]

🕵️ Fake follower check 📊 Engagement rate 💰 What they charge

💡 Facts

📤Posts about 0.1× per week.

👥 Audience demographics

Estimated

Modeled from this creator's niche, platform & region — a planning estimate, not connected analytics.

Gender split

Male 72% Female 28%

Age · peak 18-24

13-1712%

18-2434%

25-3428%

35-4417%

45+9%

Top geographies

United States34%
India11%
United Kingdom8%
Brazil6%
Indonesia5%

Likely interests

EntertainmentLifestyleTrending

About

Recent advances in understanding steatotic liver disease have revealed overlapping biological processes that may contribute to non-alcoholic fatty liver disease (NAFLD). Join us in this podcast series where your colleagues will take you on a journey to better understand the cardiometabolic basis for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), which has long been recognized as “the hepatic manifestation of the metabolic syndrome.” In this series, we will explore MASH, including epidemiology, pathophysiology, comorbidities, patients at risk, and HCP perspectives on the patient journey. This series is tailored specifically for healthcare professionals seeking deeper insights into MASH. Expose MASH [Formerly NASH] is tailored for healthcare professionals seeking to stay at the forefront of liver disease knowledge. This podcast is sponsored by Novo Nordisk and is intended for U.S. clinicians. This podcast is not to be used as medical advice.